Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report

Peripheral T-cell lymphoma (PTCL) represents a small heterogeneous group of non-Hodgkin lymphoma (NHL) that accounts for ~10% of NHLs in western countries and ~25% of NHLs in Japan. The disease remains extremely difficult to treat. Therefore, novel treatment modalities are required. Mogamulizumab is...

Descripción completa

Detalles Bibliográficos
Autores principales: FUJITA, YUKIE, NAKAYA, AYA, FUJITA, SHINYA, HOTTA, MASAAKI, YOSHIMURA, HIDEAKI, AZUMA, YOSHIKO, NAKANISHI, TAKAHISA, SATAKE, ATSUSHI, ISHII, KAZUYOSHI, ITO, TOMOKI, NOMURA, SHOSAKU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734048/
https://www.ncbi.nlm.nih.gov/pubmed/26893851
http://dx.doi.org/10.3892/mco.2015.695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734048/
https://www.ncbi.nlm.nih.gov/pubmed/26893851
http://dx.doi.org/10.3892/mco.2015.695

Ejemplares similares